AMLODIN

Amlodin Adverse Events Reported to the FDA Over Time

How are Amlodin adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Amlodin, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Amlodin is flagged as the suspect drug causing the adverse event.

Most Common Amlodin Adverse Events Reported to the FDA

What are the most common Amlodin adverse events reported to the FDA?

Hypotension	17 (1.71%)
Renal Failure Acute	17 (1.71%)
Platelet Count Decreased	15 (1.51%)
Bradycardia	14 (1.41%)
Overdose	14 (1.41%)
Haemoglobin Decreased	13 (1.31%)
Tubulointerstitial Nephritis	13 (1.31%)
Blood Pressure Decreased	12 (1.21%)
Pancytopenia	12 (1.21%)
Pyrexia	12 (1.21%)
Rhabdomyolysis	12 (1.21%)
	Show More
Depressed Level Of Consciousness	11 (1.11%)
Leukocytoclastic Vasculitis	11 (1.11%)
White Blood Cell Count Decreased	11 (1.11%)
Blood Creatinine Increased	9 (.91%)
Blood Lactate Dehydrogenase Increas...	9 (.91%)
C-reactive Protein Increased	9 (.91%)
Haematocrit Decreased	9 (.91%)
Alanine Aminotransferase Increased	8 (.8%)
Aspartate Aminotransferase Increase...	8 (.8%)
Atrial Fibrillation	8 (.8%)
Blood Urea Increased	8 (.8%)
Dyspnoea	8 (.8%)
Hyperkalaemia	8 (.8%)
Hypoglycaemia	8 (.8%)
Intentional Overdose	8 (.8%)
Liver Disorder	8 (.8%)
Malaise	8 (.8%)
Shock	8 (.8%)
Vomiting	8 (.8%)
Cardiac Failure	7 (.7%)
Interstitial Lung Disease	7 (.7%)
Nausea	7 (.7%)
Nephrotic Syndrome	7 (.7%)
Rash	7 (.7%)
Red Blood Cell Count Decreased	7 (.7%)
Blood Alkaline Phosphatase Increase...	6 (.6%)
Blood Creatine Phosphokinase Increa...	6 (.6%)
Duodenal Ulcer Perforation	6 (.6%)
Gait Disturbance	6 (.6%)
Gamma-glutamyltransferase Increased	6 (.6%)
Glomerulonephritis Membranous	6 (.6%)
Hepatic Function Abnormal	6 (.6%)
Oedema	6 (.6%)
Pleural Effusion	6 (.6%)
Pneumonia	6 (.6%)
Renal Disorder	6 (.6%)
Renal Impairment	6 (.6%)
Suicide Attempt	6 (.6%)
Thrombocytopenia	6 (.6%)
Toxic Epidermal Necrolysis	6 (.6%)
Tremor	6 (.6%)
Urine Output Decreased	6 (.6%)
Agranulocytosis	5 (.5%)
Blood Bilirubin Increased	5 (.5%)
Cardio-respiratory Arrest	5 (.5%)
Cerebral Infarction	5 (.5%)
Drug Interaction	5 (.5%)
Femur Fracture	5 (.5%)
Hemiplegia	5 (.5%)
Hepatitis Acute	5 (.5%)
Hyponatraemia	5 (.5%)
Iga Nephropathy	5 (.5%)
Loss Of Consciousness	5 (.5%)
Nephropathy	5 (.5%)
Oedema Peripheral	5 (.5%)
Parkinsonism	5 (.5%)
Sepsis	5 (.5%)
Abdominal Pain	4 (.4%)
Accidental Overdose	4 (.4%)
Allergic Granulomatous Angiitis	4 (.4%)
Anorexia	4 (.4%)
Aortic Dissection	4 (.4%)
Atrioventricular Block	4 (.4%)
Cardiac Arrest	4 (.4%)
Cardiac Failure Congestive	4 (.4%)
Convulsion	4 (.4%)
Dermatitis Contact	4 (.4%)
Diabetic Hyperosmolar Coma	4 (.4%)
Diabetic Nephropathy	4 (.4%)
Disseminated Intravascular Coagulat...	4 (.4%)
Drug Eruption	4 (.4%)
Gamma-glutamyltransferase Abnormal	4 (.4%)
Hepatitis Fulminant	4 (.4%)
Lymphocyte Stimulation Test Positiv...	4 (.4%)
Metabolic Acidosis	4 (.4%)
Muscular Weakness	4 (.4%)
Neurogenic Bladder	4 (.4%)
Neurosis	4 (.4%)
Penile Ulceration	4 (.4%)
Phlebitis	4 (.4%)
Renal Failure	4 (.4%)
Scrotal Ulcer	4 (.4%)
Thrombotic Thrombocytopenic Purpura	4 (.4%)
Acute Myocardial Infarction	3 (.3%)
Altered State Of Consciousness	3 (.3%)
Anaemia	3 (.3%)
Aplastic Anaemia	3 (.3%)
Bleeding Time Prolonged	3 (.3%)
Blood Creatine Increased	3 (.3%)
Blood Creatinine Abnormal	3 (.3%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Amlodin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Amlodin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Amlodin

What are the most common Amlodin adverse events reported to the FDA?

Hematology Investigations	81 (8.15%)
Cardiac Arrhythmias	45 (4.53%)
Nephropathies	41 (4.12%)
Neurological	41 (4.12%)
Renal Disorders	38 (3.82%)
Epidermal And Dermal Conditions	35 (3.52%)
Hepatobiliary	32 (3.22%)
Renal And Urinary Tract Investigati...	30 (3.02%)
Medication Errors	29 (2.92%)
Decreased And Nonspecific Blood Pre...	27 (2.72%)
Hepatic And Hepatobiliary	26 (2.62%)
	Show More
Anemias Nonhemolytic And Marrow Dep...	24 (2.41%)
Enzyme	23 (2.31%)
Gastrointestinal Signs	23 (2.31%)
Infections - Pathogen Unspecified	22 (2.21%)
Muscle	21 (2.11%)
Electrolyte And Fluid Balance Condi...	20 (2.01%)
Cardiac And Vascular Investigations	19 (1.91%)
Movement Disorders	17 (1.71%)
Respiratory	16 (1.61%)
Body Temperature Conditions	14 (1.41%)
Glucose Metabolism Disorders	14 (1.41%)
Lower Respiratory Tract Disorders	14 (1.41%)
Skin Vascular Abnormalities	13 (1.31%)
Platelet	12 (1.21%)
Central Nervous System Vascular	11 (1.11%)
Heart Failures	11 (1.11%)
Protein And Chemistry Analyses	11 (1.11%)
Therapeutic And Nontherapeutic Effe...	10 (1.01%)
Suicidal And Self-injurious Behavio...	8 (.8%)
White Blood Cell	8 (.8%)
Gastrointestinal Motility And Defec...	7 (.7%)
Gastrointestinal Ulceration And Per...	7 (.7%)
Gastrointestinal Inflammatory Condi...	6 (.6%)
Pleural	6 (.6%)
Skin And Subcutaneous Tissue	6 (.6%)
Water, Electrolyte And Mineral	6 (.6%)
Angiedema And Urticaria	5 (.5%)
Appetite And General Nutritional	5 (.5%)
Arteriosclerosis, Stenosis, Vascula...	5 (.5%)
Benign Neoplasms Gastrointestinal	5 (.5%)
Bone And Joint Injuries	5 (.5%)
Coagulopathies And Bleeding Diathes...	5 (.5%)
Metabolic, Nutritional And Blood Ga...	5 (.5%)
Seizures	5 (.5%)
Urinary Tract Signs	5 (.5%)
Acid-base	4 (.4%)
Aneurysms And Artery Dissections	4 (.4%)
Anxiety Disorders	4 (.4%)
Bladder And Bladder Neck Disorders	4 (.4%)
Coronary Artery	4 (.4%)
Gastrointestinal Neoplasms Malignan...	4 (.4%)
Penile And Scrotal Disorders	4 (.4%)
Physical Examination Topics	4 (.4%)
Vascular Inflammations	4 (.4%)
Cardiac Disorder Signs	3 (.3%)
Dental And Gingival Conditions	3 (.3%)
Gallbladder	3 (.3%)
Joint	3 (.3%)
Musculoskeletal And Connective Tiss...	3 (.3%)
Peripheral Neuropathies	3 (.3%)
Sexual Function And Fertility	3 (.3%)
Upper Respiratory Tract Disorders	3 (.3%)
Vascular	3 (.3%)
Vascular Hypertensive	3 (.3%)
Allergic Conditions	2 (.2%)
Breast	2 (.2%)
Bronchial Disorders	2 (.2%)
Cardiac Valve	2 (.2%)
Chemical Injury And Poisoning	2 (.2%)
Exocrine Pancreas Conditions	2 (.2%)
Gastrointestinal Therapeutic Proced...	2 (.2%)
Hematological	2 (.2%)
Hemolyses And Related Conditions	2 (.2%)
Immunology And Allergy	2 (.2%)
Injuries	2 (.2%)
Lymphomas Non-hodgkins B-cell	2 (.2%)
Neurological, Special Senses And Ps...	2 (.2%)
Peritoneal And Retroperitoneal Cond...	2 (.2%)
Spleen, Lymphatic And Reticulendoth...	2 (.2%)
Structural Brain	2 (.2%)
Thyroid Gland	2 (.2%)
Vascular Therapeutic Procedures	2 (.2%)
Administration Site Reactions	1 (.1%)
Anterior Eye Structural Change, Dep...	1 (.1%)
Bacterial Infectious	1 (.1%)
Cranial Nerve Disorders	1 (.1%)
Cutaneous Neoplasms Benign	1 (.1%)
Fatal Outcomes	1 (.1%)
Hematological And Lymphoid Tissue T...	1 (.1%)
Immune	1 (.1%)
Leukemias	1 (.1%)
Lipid Analyses	1 (.1%)
Miscellaneous And Site Unspecified ...	1 (.1%)
Musculoskeletal And Soft Tissue Inv...	1 (.1%)
Ocular Neuromuscular	1 (.1%)
Protein And Amino Acid Metabolism	1 (.1%)
Red Blood Cell	1 (.1%)
Respiratory And Mediastinal Neoplas...	1 (.1%)
Respiratory And Pulmonary Investiga...	1 (.1%)
Respiratory Tract Therapeutic Proce...	1 (.1%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Amlodin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Amlodin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.